Inhibrx Biosciences Inc (INBX)
R&D to Revenue
0.00%
Quarterly · Period ending:
INBX R&D to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
INBX Quarterly R&D/Revenue (2593.95% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
INBX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 1,712.8462% | |
| 0% | |
| 33,367% | |
| 0% | |
| 67,632% | |
| 0% | |
| 5,008.5067% | |
| 31,980.6723% | |
| 112,880% | |
| 218,523.5294% | |
| 11,113.5036% | |
| 8,969.0647% | |
| 4,206.1885% | |
| 2,720.765% | |
| 656.3822% | |
| 730.0553% | |
| 1,876.5199% | |
| 1,904.7509% | |
| 636.4553% | |
| 340.4909% | |
| 569.1062% | |
| 1,951.3761% | |
| 4,600.3745% | |
| 1,610.2015% | |
| 1,217.4% | |
| 151.6638% | |
| 206.2583% | |
| 339.8% | |
| 431.16% | |
| 2,593.9502% |